Related Experiment Video
Updated: Feb 22, 2026

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
Poly(N-(2-Hydroxypropyl) Methacrylamide)-Valproic Acid Conjugates as Block Copolymer Nanocarriers
Jawaher A Alfurhood1, Hao Sun1, Christopher P Kabb1
1George & Josephine Butler Polymer Research Laboratory, Center for Macromolecular Science & Engineering, Department of Chemistry, University of Florida, PO Box 117200, Gainesville, FL 32611-7200, USA.
New nanoassemblies using N-(2-hydroxypropyl) methacrylamide (HPMA) block copolymers improve drug delivery. Drug release regenerates HPMA, enhancing biocompatibility and enabling stimuli-responsive delivery in acidic environments.
Area of Science:
- Polymer Chemistry
- Biomaterials Science
- Drug Delivery Systems
Background:
- Block copolymers are crucial in advanced materials.
- Biocompatibility is a key challenge in polymer-based drug delivery.
- Stimuli-responsive systems offer targeted therapeutic approaches.
Purpose of the Study:
- To develop novel nanoassemblies for enhanced drug delivery.
- To improve the biological compatibility of polymer carriers.
- To investigate stimuli-responsive drug release mechanisms.
Main Methods:
- Synthesis of N-(2-hydroxypropyl) methacrylamide (HPMA) block copolymers.
- Formation of nanoassemblies.
- Drug loading and in vitro release studies.
- Assessment of biological compatibility post-drug cleavage.
Main Results:
- Successfully formed HPMA-based block copolymer nanoassemblies.
- Demonstrated drug cleavage via ester hydrolysis.
- Observed enhanced biological compatibility upon regeneration of HPMA units.
- Indicated potential for acidic pH-triggered drug release.
Conclusions:
- HPMA-based nanoassemblies offer a promising platform for drug delivery.
- Drug cleavage and regeneration of HPMA units improve biocompatibility.
- Ester hydrolysis-mediated release enables stimuli-responsive, targeted delivery.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I

